Biomarker for Gaucher Disease: BioGaucher (BioGaucher)
NCT01331642 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2023-02-13
Summary
Development of a new mass spectrometry-based biomarker for the early and sensitive diagnosis of Gaucher Disease from blood (plasma)
Conditions
- Splenomegaly
- Hepatomegaly
Sponsors & Collaborators
-
CENTOGENE GmbH Rostock
lead INDUSTRY
Principal Investigators
-
Peter Bauer, Prof. · Centogene GmbH
Eligibility
- Min Age
- 1 Day
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-08-20
- Primary Completion
- 2021-02-28
- Completion
- 2021-02-28
Countries
- Germany
- India
- Sri Lanka
Study Locations
More Related Trials
-
B7 Coreceptor Molecules in Hyper IgD Syndrome Form of Mevalonate Kinase Deficiency
NCT01568736 ·Status: WITHDRAWN
-
Examining the Immune Response in Patients With Gaucher Disease and Hepatitis C
NCT01274208 ·Status: UNKNOWN
-
Surveillance for Early Liver Injuries Caused by Zhuanggu Guanjie Pill
NCT03060252 ·Status: UNKNOWN
-
Giant Cell Arteritis - Optimization of Diagnostics
NCT05248906 ·Status: COMPLETED
-
Polymorphism of ITGA4 Gene in Chronic Lymphocytic Leukemia
NCT05371392 ·Status: NOT_YET_RECRUITING
-
Investigation of the Influence of the Human Microbiome on Giant Cell Arteritis
NCT06279065 ·Status: RECRUITING
-
Bile Usefulness for Detecting IgG4-related Sclerosing Cholangitis
NCT02616705 ·Status: COMPLETED
-
Whole Blood Biospecimen Collection for Subjects With Chronic Granulomatous Disease (CGD)
NCT05915897 ·Status: TERMINATED
-
Cell Bound Complement Activation Proteins as Markers of Liver Injury
NCT01025531 ·Status: WITHDRAWN
-
Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
NCT02257866 ·Status: RECRUITING
-
Biomarkers for Intestinal Permeability
NCT04667208 ·Status: COMPLETED
-
Predictive Markers of the Course of Covid-19 Based on Biomarker Serum Amyloid A (SAA) and Genetic Markers
NCT07120269 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Autoimmune Hepatitis Study
NCT00286663 ·Status: TERMINATED
-
GammaGA: Prevalence of Acid Sphingomyelinase Deficiency Disease (ASMD) and Gaucher Disease in Patients With Monoclonal Gammopathies and/or Multiple Myeloma
NCT05992532 ·Status: RECRUITING
-
Glycosylated Ferritin in Macrophagic Activation Syndromes
NCT02143986 ·Status: RECRUITING
-
A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
NCT07146906 ·Status: RECRUITING ·Phase: PHASE2
-
Studies on the Expression and Functions of RLIP76 in Blood Samples of Healthy Human Subjects
NCT00762801 ·Status: WITHDRAWN
-
sgp130 in Chronic Human Liver Disease
NCT00770198 ·Status: COMPLETED
-
Prevalence of Circulating Parvovirus Genome in Recently Diagnosed Graves' Disease: a Case-control Study
NCT02798965 ·Status: COMPLETED ·Phase: NA
-
Diagnostic and Prognostic Biomarkers for IgG4-related Disease.
NCT05901207 ·Status: UNKNOWN
-
Cytokines and the Risk of Infection in Liver Cirrhosis
NCT00857181 ·Status: TERMINATED
-
Retrospective Study for Diagnosis of Undetected IgG4 Related Diseases in Patients With High Serum IgG4 Levels.
NCT02229448 ·Status: COMPLETED
-
Albumin Modifications as Early Biomarkers of Chronic Liver Diseases
NCT06318949 ·Status: RECRUITING ·Phase: NA
-
Gene Expression in Liver Allograft Rejection and Recurrent Hepatitis C
NCT01428700 ·Status: COMPLETED
-
A Study on Factors of Biochemical Response in Autoimmune Hepatitis
NCT06356506 ·Status: NOT_YET_RECRUITING